Drug Development

Articles

The partnership, co-funded by Enterprise Ireland, will develop technologies for monitoring the quality of biopharma processes.

NIBRT, Valitacell Aim to Validate New Analytical Technology

ADC Biotechnology will invest downstream formulation, fill/finish capabilities, and Lock-Release conjugation technology.

ADC Bio Secures Additional Equity Round Investment

The University of South Australia is working to develop needle-free vaccines for Zika, chikingunya, and peanut allergy in a collaboration with Australian biotechnology company Sementis and Enesi Pharma, a United Kingdom-based pharmaceutical company.

International Partnership Aims to Develop Needle-free Vaccines

The vaccine producer announced an expansion to its Holly Springs, NC, manufacturing facility where it will increase production of its cell-based quadrivalent influenza vaccine.

Seqirus Announces $140-Million Expansion for Vaccine Facility

Pharmapack Europe expects further increases in innovation across packaging and drug delivery to mirror overall industry trends.

Pharmapack Expects Accelerated Growth in Drug Delivery and Packaging, Mirroring Overall Industry

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Moving forward with gene therapy development requires a “quantum leap” in manufacturing capabilities. 

Manufacturing Challenges Limit Gene Therapy Development

The testing of raw materials is essential as raw material quality determines the outcome of biologic product quality.

Analytical Best Practices for Raw Materials Testing

The new program will provide cell and gene therapy companies a more efficient way to ensure quality compliance across collection center networks and to minimize quality system audit burden on these centers.

Be The Match BioTherapies Launches Program for Faster Cell Facility Onboarding

Permission from the United Kingdom's Supreme Court has been granted to the UK BioIndustry Association, allowing it to intervene in a dosage regimen patent case.

UK Supreme Court Grants Permission to UK BioIndustry Association to Intervene in Case

Medherant has announced positive results from two Phase I trials evaluating its transdermal drug delivery patch loaded with ibuprofen.

Formulation and Drug Delivery